High-Priced Medicines and Lack of Needs-Driven Innovation: A global crisis that fuels inequality

by Mohga Kamal Yanni, Sara Albiani and Stephanie Burgos
OXFAM International Issue Briefing, September 2017

12 pp.446 kB
https://oxfamilibrary.openrepository.com/oxfam/bitstream/10546/620342/1/ib-high-
priced-medicines-innovation-220917-en.pdf

On 14 September 2016, the UN Secretary-General’s High-Level Panel on Access to Medicines publicly released its final report entitled ‘Promoting innovation and access to health technologies’. One year after the release of the landmark report and building upon Oxfam’s September 2016 assessment, this paper provides an update on where the High-Level Panel (HLP) report and its recommendations stand. It assesses the level of implementation by countries and institutions – especially the UN and the World Health Organization – and recommends ways to use the report to improve both innovation and access to medicines.

(Visited 7 times, 1 visits today)
This entry was posted in Essential Medicines, General, Global Health. Bookmark the permalink.